Evaluation of the application of high volume hemofiltration in sepsis combined with acute kidney injury

Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):715-720. doi: 10.26355/eurrev_201802_14298.

Abstract

Objective: To investigate the safety and effectiveness of the application of high-volume hemofiltration (HVHF) in children with sepsis combined with acute kidney injury.

Patients and methods: A total of 76 child patients were enrolled and randomly divided equally (n=38) into control and the observation groups respectively. The control group received conventional volume hemofiltration (the ultrafiltration rate of 35-50 ml/kg/h), and the observation group received HVHF (50-100 ml/kg/h).

Results: The serum Interleukin-6 (IL-6), Tumor Necrosis Factor-a (TNF-α) and creatinine levels were significantly lower in the observation group than the control group at 6 h, 12 h, 24 h and 48 h of hemofiltration (p<0.05). The efficacy rate of treatment was improved. The mortality rate and incidence rate of complications were decreased, and the treatment course was significantly shortened (p<0.05).

Conclusions: The application of HVHF in children with sepsis combined with acute kidney injury has a better safety and effectiveness.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acute Kidney Injury / therapy*
  • Child
  • Child, Preschool
  • Female
  • Hemofiltration / methods*
  • Humans
  • Interleukin-6 / blood
  • Male
  • Sepsis / therapy*
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Interleukin-6
  • Tumor Necrosis Factor-alpha